Article
A signature-agnostic test for differences between tumor mutation spectra reveals carcinogen and ancestry effects
2025-05-19
Abstract excerpt
Despite dozens of tools to identify mutational signatures in cancer samples, there is not an established metric for quantifying whether signature exposures differ significantly between two heterogeneous groups of samples. We demonstrate that a signature-agnostic metric - the aggregate mutation spectrum distance permutation method (AMSD) - can rigorously determine whether mutational exposures differ between groups,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ccbc9691-930b-509a-b489-30b4553a800a
- DOI
- 10.1101/2025.05.15.654154